Trials / Recruiting
RecruitingNCT04119102
Duobrii in Combination With Biologics
Open Label Study Evaluating DUOBRII in Psoriasis Patients Being Treated With Biologic Agents.
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Psoriasis Treatment Center of Central New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
Detailed description
A single center, pilot study of 25 subjects to assess 12 weeks DUOBRII to patients with 2%-10% body surface area who are receiving biologic therapy for at least 24 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duobrii | duobrii applied daily for 4 weeks followed by every other day for 4 weeks. |
Timeline
- Start date
- 2019-10-14
- Primary completion
- 2020-08-01
- Completion
- 2020-09-01
- First posted
- 2019-10-08
- Last updated
- 2020-04-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04119102. Inclusion in this directory is not an endorsement.